Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 706314, 8 pages
http://dx.doi.org/10.1155/2014/706314
Research Article

Study of Leptin and Adiponectin as Disease Markers in Subjects with Obstructive Sleep Apnea

1Department of Medicine, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat, 13110 Kuwait City, Kuwait
2Department of Pathology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat, 13110 Kuwait City, Kuwait
3Department of Medicine, Al-Amiri Hospital, Ministry of Health, P.O. Box 4077, Safat, 13041 Kuwait City, Kuwait

Received 9 January 2014; Revised 24 April 2014; Accepted 1 May 2014; Published 29 May 2014

Academic Editor: Francisco Blanco-Vaca

Copyright © 2014 Sana Al Mutairi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. O. Bixler, A. N. Vgontzas, H.-M. Lin et al., “Prevalence of sleep-disordered breathing in women: effects of gender,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, pp. 608–613, 2001. View at Google Scholar · View at Scopus
  2. S. Redline, K. Kump, P. V. Tishler, I. Browner, and V. Ferrette, “Gender differences in sleep disordered breathing in a community-based sample,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, pp. 722–726, 1994. View at Google Scholar · View at Scopus
  3. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, “The occurrence of sleep-disordered breathing among middle-aged adults,” The New England Journal of Medicine, vol. 328, no. 17, pp. 1230–1235, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. A. B. Newman, F. J. Nieto, U. Guidry et al., “Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study,” American Journal of Epidemiology, vol. 154, no. 1, pp. 50–59, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Young, E. Shahar, F. J. Nieto et al., “Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study,” Archives of Internal Medicine, vol. 162, no. 8, pp. 893–900, 2002. View at Google Scholar · View at Scopus
  6. E. O. Bixler, A. N. Vgontzas, T. ten Have, K. Tyson, and A. Kales, “Effects of age on sleep apnea in men. I. Prevalence and severity,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 1, pp. 144–148, 1998. View at Google Scholar · View at Scopus
  7. S. Redline, P. V. Tishler, M. G. Hans, T. D. Tosteson, K. P. Strohl, and K. Spry, “Racial differences in sleep-disordered breathing in African-Americans and Caucasians,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 1, pp. 186–192, 1997. View at Google Scholar
  8. R. J. O. Davies, N. J. Ali, and J. R. Stradling, “Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome,” Thorax, vol. 47, no. 2, pp. 101–105, 1992. View at Google Scholar · View at Scopus
  9. R. J. O. Davies and J. R. Stradling, “The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apneoa syndrome,” European Respiratory Journal, vol. 3, no. 5, pp. 509–514, 1990. View at Google Scholar · View at Scopus
  10. V. Hoffstein and S. Mateika, “Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea,” European Respiratory Journal, vol. 5, no. 4, pp. 377–381, 1992. View at Google Scholar · View at Scopus
  11. I. Katz, J. Stradling, A. S. Slutsky, N. Zamel, and V. Hoffstein, “Do patients with obstructive sleep apnea have thick necks?” American Review of Respiratory Disease, vol. 141, no. 5, pp. 1228–1231, 1990. View at Google Scholar · View at Scopus
  12. G. V. Robinson, J. R. Stradling, and R. J. O. Davies, “Sleep6: obstructive sleep apnoea/hypopnoea syndrome and hypertension,” Thorax, vol. 59, no. 12, pp. 1089–1094, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. S. Hamilton, P. Solin, and M. T. Naughton, “Obstructive sleep apnoea and cardiovascular disease,” Internal Medicine Journal, vol. 34, no. 7, pp. 420–426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Lurie, “Metabolic disorders associated with obstructive sleep apnea in adults,” Advances in Cardiology, vol. 46, pp. 67–138, 2011. View at Publisher · View at Google Scholar
  15. N. M. Punjabi and V. Y. Polotsky, “Disorders of glucose metabolism in sleep apnea,” Journal of Applied Physiology, vol. 99, no. 5, pp. 1998–2007, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K.-I. Takahashi, K. Chin, H. Nakamura et al., “Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure,” Antioxidants and Redox Signaling, vol. 10, no. 4, pp. 715–726, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Trujillo and P. E. Scherer, “Adiponectin—journey from an adipocyte secretory protein to biomarker of the metabolic syndrome,” Journal of Internal Medicine, vol. 257, no. 2, pp. 167–175, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. M. Ip, B. Lam, M. M. T. Ng, W. K. Lam, K. W. T. Tsang, and K. S. L. Lam, “Obstructive sleep apnea is independently associated with insulin resistance,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 670–676, 2002. View at Google Scholar · View at Scopus
  19. A. Barceló, F. Barbé, M. de la Peña et al., “Insulin resistance and daytime sleepiness in patients with sleep apnoea,” Thorax, vol. 63, no. 11, pp. 946–950, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. P. E. Ronksley, B. R. Hemmelgarn, S. J. Heitman et al., “Obstructive sleep apnoea is associated with diabetes in sleepy subjects,” Thorax, vol. 64, no. 10, pp. 834–839, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Tokuda, Y. Sando, H. Matsui, H. Koike, and T. Yokoyama, “Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome,” Internal Medicine, vol. 47, no. 21, pp. 1843–1849, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Sánchez-de-la-Torre, O. Median, A. Barceló et al., “The influence of obesity and obstructive sleep apnea on metabolic hormones,” Sleep and Breathing, vol. 16, no. 3, pp. 649–656, 2012. View at Publisher · View at Google Scholar
  23. T. A. Hargens, S. G. Guill, A. S. Kaleth et al., “Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea,” Sleep and Breathing, vol. 17, no. 1, pp. 403–409, 2013. View at Publisher · View at Google Scholar
  24. AARC-APT (American Association of Polysomnography Technologists) Clinical Practice Guidelines, “Polysomnography,” Respiratory Care, vol. 40, no. 12, pp. 1336–1343, 1995. View at Google Scholar
  25. L. J. Epstein, D. Kristo, P. J. Strollo Jr. et al., “Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults,” Journal of Clinical Sleep Medicine, vol. 5, no. 3, pp. 263–276, 2009. View at Google Scholar · View at Scopus
  26. C. Iber, S. Ancoli-Israel, A. L. Chesson, and S. F. Quan, American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, American Academi of Sleep Medicine, Westchester, NY, USA, 1st edition, 2007.
  27. M. Friedman, H. Tanyeri, M. la Rosa et al., “Clinical predictors of obstructive sleep apnea,” Laryngoscope, vol. 109, no. 12, pp. 1901–1907, 1999. View at Google Scholar · View at Scopus
  28. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report,” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. O. A. Mojiminiyi, F. Al Mulla, and N. A. Abdella, “Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus?” Medical Principles and Practice, vol. 18, no. 2, pp. 123–129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  31. C. P. O'Donnell, C. D. Schaub, A. S. Haines et al., “Leptin prevents respiratory depression in obesity,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 5, pp. 1477–1484, 1999. View at Google Scholar · View at Scopus
  32. V. Y. Polotsky, J. Li, N. M. Punjabi et al., “Intermittent hypoxia increases insulin resistance in genetically obese mice,” Journal of Physiology, vol. 552, no. 1, pp. 253–264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Makino, H. Handa, K. Suzukawa et al., “Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance,” Clinical Endocrinology, vol. 64, no. 1, pp. 12–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Nakagawa, K. Kishida, S. Kihara et al., “Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome,” American Journal of Physiology: Endocrinology and Metabolism, vol. 294, no. 4, pp. E778–E784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Ye, Z. Gao, J. Yin, and Q. He, “Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice,” American Journal of Physiology: Endocrinology and Metabolism, vol. 293, no. 4, pp. E1118–E1128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. J. C. M. Lam, A. Xu, S. Tam et al., “Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea,” Sleep, vol. 31, no. 12, pp. 1721–1727, 2008. View at Google Scholar · View at Scopus
  37. W. T. McNicholas, M. R. Bonsignore, and The Management Committee of EU COST ACTION B26, “Sleep apnoea as an independent risk for cardiovascular disease: current evidence, basic mechanisms and research priorities,” European Respiratory Journal, vol. 29, no. 1, pp. 156–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. Stoohs, G. Facchini, and C. Guilleminault, “Insulin resistance and sleep-disordered breathing in healthy humans,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 1, pp. 170–174, 1996. View at Publisher · View at Google Scholar